faculty_name,faculty_email,publication_type,title,journal,year,doi,url,file_created
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Left atrial appendage occlusion study III-Kidney substudy.,American Heart Journal,2025,10.1016/j.ahj.2025.04.018,https://experts.mcmaster.ca/display/publication3574474,2025-07-27T15:14:40.642925
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,The authors reply,Kidney International,2025,10.1016/j.kint.2025.04.022,https://experts.mcmaster.ca/display/publication3610238,2025-07-27T15:14:40.642929
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Outcomes in New User Cohorts of SGLT2 Inhibitors or GLP-1 Receptor Agonists with Type 2 Diabetes and Chronic Kidney Disease.,Diabetes Therapy,2025,10.1007/s13300-025-01750-7,https://experts.mcmaster.ca/display/publication3592983,2025-07-27T15:14:40.642931
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Efficacy and safety of avacopan in patients aged 65 years and older with ANCA-associated vasculitis: a post hoc analysis of data from the ADVOCATE trial.,Rheumatology,2025,10.1093/rheumatology/keaf122,https://experts.mcmaster.ca/display/publication3591078,2025-07-27T15:14:40.642932
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Risk factors associated with Gastrointestinal Bleeding in Patients with Cardiovascular Disease (INTERBLEED): a case control study.,European Journal of Preventive Cardiology (EJPC),2025,10.1093/eurjpc/zwaf300,https://experts.mcmaster.ca/display/publication3585329,2025-07-27T15:14:40.642933
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Anticoagulation for Patients with Atrial Fibrillation Receiving Dialysis: A Pilot Randomized Controlled Trial.,Journal of the American Society of Nephrology,2025,10.1681/ASN.0000000000000495,https://experts.mcmaster.ca/display/publication3484596,2025-07-27T15:14:40.642934
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Clinical Profile and Treatment Patterns in Individuals with Type 2 Diabetes and Chronic Kidney Disease Who Initiate a GLP-1 Receptor Agonist: A Multinational Cohort Study.,Diabetes Therapy,2025,10.1007/s13300-025-01717-8,https://experts.mcmaster.ca/display/publication3561851,2025-07-27T15:14:40.642935
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Does plasma exchange have a role in ANCA-associated vasculitis? Viewpoint 1: plasma exchange should not be used indiscriminately.,Rheumatology,2025,10.1093/rheumatology/keaf011,https://experts.mcmaster.ca/display/publication3557917,2025-07-27T15:14:40.642936
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trial.,Kidney International,2025,10.1016/j.kint.2024.11.029,https://experts.mcmaster.ca/display/publication3505514,2025-07-27T15:14:40.642937
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Heart failure events in randomized controlled trials for adults receiving maintenance dialysis: a meta-epidemiologic study,Nephrology Dialysis Transplantation,2025,10.1093/ndt/gfae156,https://experts.mcmaster.ca/display/publication3448312,2025-07-27T15:14:40.642938
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Clinical Profile and Treatment Adherence in Patients with Type 2 Diabetes and Chronic Kidney Disease Who Initiate an SGLT2 Inhibitor: A Multi-cohort Study.,Diabetes Therapy,2025,10.1007/s13300-024-01671-x,https://experts.mcmaster.ca/display/publication3505513,2025-07-27T15:14:40.642939
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Preoperative estimated glomerular filtration rate to predict cardiac events in major noncardiac surgery: a secondary analysis of two large international studies.,British Journal of Anaesthesia,2025,10.1016/j.bja.2024.10.039,https://experts.mcmaster.ca/display/publication3515874,2025-07-27T15:14:40.642940
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Bayesian Analysis of Time-To-Event Data in a Cluster-Randomized Trial: Major Outcomes With Personalized Dialysate TEMPerature (MyTEMP) Trial.,Canadian Journal of Kidney Health and Disease,2025,10.1177/20543581251341710,https://experts.mcmaster.ca/display/publication3603622,2025-07-27T15:14:40.642941
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Change in Urine Albumin-Creatinine Ratio and Occurrence of Hyperkalemia in Patients Initiating Finerenone in the USA: A Cohort Study from the FOUNTAIN Platform.,Nephron,2025,10.1159/000543923,https://experts.mcmaster.ca/display/publication3568673,2025-07-27T15:14:40.642942
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,The Aldosterone Blockade for Health Improvement Evaluation in End-Stage Renal Disease (ACHIEVE) Trial: Rationale and Clinical Research Protocol.,Canadian Journal of Kidney Health and Disease,2025,10.1177/20543581251348187,https://experts.mcmaster.ca/display/publication3592889,2025-07-27T15:14:40.642943
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Authors' Reply: Proton Pump Inhibitors May Cause a Decline in eGFR by Inhibiting Organic Cation Transporter 2-Dependent Creatinine Secretion.,Journal of the American Society of Nephrology,2024,10.1681/ASN.0000000000000464,https://experts.mcmaster.ca/display/publication3461976,2025-07-27T15:14:40.642944
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Risk of Relapse of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in a Randomized Controlled Trial of Plasma Exchange and Glucocorticoids,Arthritis & Rheumatology,2024,10.1002/art.42843,https://experts.mcmaster.ca/display/publication3406662,2025-07-27T15:14:40.642945
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Glucocorticoid Minimization in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: An International Survey of Clinicians,Kidney Medicine,2024,10.1016/j.xkme.2024.100858,https://experts.mcmaster.ca/display/publication3454193,2025-07-27T15:14:40.642946
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis,Kidney International,2024,10.1016/j.kint.2024.02.024,https://experts.mcmaster.ca/display/publication3409038,2025-07-27T15:14:40.642947
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,The Effects of Pantoprazole on Kidney Outcomes,Journal of the American Society of Nephrology,2024,10.1681/asn.0000000000000356,https://experts.mcmaster.ca/display/publication3412903,2025-07-27T15:14:40.642948
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Mental health and addiction service utilization among people living with chronic kidney disease,Nephrology Dialysis Transplantation,2024,10.1093/ndt/gfad240,https://experts.mcmaster.ca/display/publication3320099,2025-07-27T15:14:40.642949
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Development and external validation of the ‘Global Surgical-Site Infection’ (GloSSI) predictive model in adult patients undergoing gastrointestinal surgery,British Journal of Surgery,2024,10.1093/bjs/znae129,https://experts.mcmaster.ca/display/publication3458999,2025-07-27T15:14:40.642949
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Alveolar Hemorrhage in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Results of an International Randomized Controlled Trial (PEXIVAS),American Journal of Respiratory and Critical Care Medicine,2024,10.1164/rccm.202308-1426oc,https://experts.mcmaster.ca/display/publication3401476,2025-07-27T15:14:40.642950
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Capacity for the management of kidney failure in the International Society of Nephrology North America and the Caribbean region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA),Kidney International Supplements,2024,10.1016/j.kisu.2024.01.003,https://experts.mcmaster.ca/display/publication3412726,2025-07-27T15:14:40.642951
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Are Observational Reports on the Association of Dialysate Sodium with Mortality Enough to Change Practice? Perspective from the RESOLVE Study Team,Journal of the American Society of Nephrology,2024,10.1681/asn.0000000000000289,https://experts.mcmaster.ca/display/publication3324024,2025-07-27T15:14:40.642952
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Characterizing Cluster-Based Frailty Phenotypes in a Multicenter Prospective Cohort of Kidney Transplant Candidates,Studies in Health Technology and Informatics,2024,10.3233/shti231094,https://experts.mcmaster.ca/display/publication3396733,2025-07-27T15:14:40.642953
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Proteome-Wide Changes in Blood Biomarkers During Hemodialysis,Kidney International Reports,2024,10.1016/j.ekir.2023.10.020,https://experts.mcmaster.ca/display/publication3319949,2025-07-27T15:14:40.642954
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,The Efficacy and Safety of Bisphosphonate Therapy for Osteopenia/Osteoporosis in Patients With Chronic Kidney Disease: A Systematic Review and Individual Patient-Level Meta-Analysis of Placebo-Controlled Randomized Trials.,Canadian Journal of Kidney Health and Disease,2024,10.1177/20543581241283523,https://experts.mcmaster.ca/display/publication3476654,2025-07-27T15:14:40.642955
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,The effect of micro-particle curcumin on chronic kidney disease progression: the MPAC-CKD randomized clinical trial,Nephrology Dialysis Transplantation,2023,10.1093/ndt/gfad037,https://experts.mcmaster.ca/display/publication3189811,2025-07-27T15:14:40.642956
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial,The Lancet Rheumatology,2023,10.1016/s2665-9913(23)00092-9,https://experts.mcmaster.ca/display/publication3279771,2025-07-27T15:14:40.642957
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,A step-by-step approach for selecting an optimal minimal important difference,The BMJ,2023,10.1136/bmj-2022-073822,https://experts.mcmaster.ca/display/publication3245866,2025-07-27T15:14:40.642958
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,An extension minimal important difference credibility item addressing construct proximity is a reliable alternative to the correlation item,Journal of Clinical Epidemiology,2023,10.1016/j.jclinepi.2023.03.001,https://experts.mcmaster.ca/display/publication3039325,2025-07-27T15:14:40.642959
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Management of antineutrophil cytoplasmic antibody-associated vasculitis: a changing tide,Current Opinion in Nephrology and Hypertension,2023,10.1097/mnh.0000000000000877,https://experts.mcmaster.ca/display/publication3067661,2025-07-27T15:14:40.642960
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Sex and Gender in Randomized Controlled Trials of Adults Receiving Maintenance Dialysis: A Meta-epidemiologic Study,American Journal of Kidney Diseases,2023,10.1053/j.ajkd.2022.10.015,https://experts.mcmaster.ca/display/publication2951541,2025-07-27T15:14:40.642961
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,The Effect of Chronic Kidney Disease or End-stage Kidney Disease on Perioperative Outcomes and Healthcare Utilization in Patients Undergoing Bariatric Surgery,Obesity Surgery,2023,10.1007/s11695-023-06542-1,https://experts.mcmaster.ca/display/publication2951778,2025-07-27T15:14:40.642962
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan,Kidney International Reports,2023,10.1016/j.ekir.2023.01.039,https://experts.mcmaster.ca/display/publication3068032,2025-07-27T15:14:40.642963
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Patient views regarding cannabis use in chronic kidney disease and kidney failure: a survey study,Nephrology Dialysis Transplantation,2023,10.1093/ndt/gfac226,https://experts.mcmaster.ca/display/publication2426259,2025-07-27T15:14:40.642964
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,High-Sensitivity Cardiac Troponin I Thresholds to Identify Myocardial Injury After Noncardiac Surgery: A Cohort Study,Canadian Journal of Cardiology,2023,10.1016/j.cjca.2023.01.008,https://experts.mcmaster.ca/display/publication2776816,2025-07-27T15:14:40.642965
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Plasma Exchange for ANCA-Associated Vasculitis: An International Survey of Patient Preferences,Kidney Medicine,2023,10.1016/j.xkme.2022.100595,https://experts.mcmaster.ca/display/publication2746209,2025-07-27T15:14:40.642966
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,“You need a team”: perspectives on interdisciplinary symptom management using patient-reported outcome measures in hemodialysis care—a qualitative study,Journal of Patient-Reported Outcomes,2023,10.1186/s41687-022-00538-8,https://experts.mcmaster.ca/display/publication2776796,2025-07-27T15:14:40.642967
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Health Services Use and Outcomes for Hospital Admissions With a Major Cardiovascular Event Recorded in Health Care Administrative Data in Patients Receiving Maintenance Hemodialysis: A Retrospective Cohort Study,Canadian Journal of Kidney Health and Disease,2023,10.1177/20543581231165708,https://experts.mcmaster.ca/display/publication3264627,2025-07-27T15:14:40.642968
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Association of abnormal electrocardiograph metrics with prolonged recovery time in incident hemodialysis patients,BMC Nephrology,2022,10.1186/s12882-022-02664-3,https://experts.mcmaster.ca/display/publication2166133,2025-07-27T15:14:40.642969
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,How the Routine Use of Patient-Reported Outcome Measures for Hemodialysis Care Influences Patient-Clinician Communication,American Society of Nephrology. Clinical Journal,2022,10.2215/cjn.05940522,https://experts.mcmaster.ca/display/publication2525853,2025-07-27T15:14:40.642970
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,INTERBLEED: Design of an International Study of Risk Factors for Gastrointestinal Bleeding and Cardiovascular Events After Gastrointestinal Bleeding,CJC OPEN,2022,10.1016/j.cjco.2022.08.002,https://experts.mcmaster.ca/display/publication2424789,2025-07-27T15:14:40.642971
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Patient Views Regarding Cannabis Use in CKD and Kidney Failure: A Survey Study,Journal of the American Society of Nephrology,2022,10.1681/asn.20223311s1695a,https://experts.mcmaster.ca/display/publication3443615,2025-07-27T15:14:40.642972
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,"Personalised cooler dialysate for patients receiving maintenance haemodialysis (MyTEMP): a pragmatic, cluster-randomised trial",The Lancet,2022,10.1016/s0140-6736(22)01805-0,https://experts.mcmaster.ca/display/publication2526146,2025-07-27T15:14:40.642973
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Sex and Gender Considerations in Randomized Controlled Trials in Adults Receiving Chronic Dialysis: A Meta-Epidemiologic Study,Journal of the American Society of Nephrology,2022,10.1681/asn.20223311s1266b,https://experts.mcmaster.ca/display/publication3443618,2025-07-27T15:14:40.642974
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,The Impact of Gender Affirming Hormone Therapy on Measures of Kidney Function: A Systematic Review and Meta-Analysis,Journal of the American Society of Nephrology,2022,10.1681/asn.20223311s1567b,https://experts.mcmaster.ca/display/publication3443617,2025-07-27T15:14:40.642974
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Plasma exchange and glucocorticoids to delay death or end-stage renal disease in anti-neutrophil cytoplasm antibody-associated vasculitis: PEXIVAS non-inferiority factorial RCT,Health Technology Assessment,2022,10.3310/pnxb5040,https://experts.mcmaster.ca/display/publication2434073,2025-07-27T15:14:40.642975
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,The Effect of Gender-Affirming Hormone Therapy on Measures of Kidney Function,American Society of Nephrology. Clinical Journal,2022,10.2215/cjn.01890222,https://experts.mcmaster.ca/display/publication2424559,2025-07-27T15:14:40.642976
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD,American Society of Nephrology. Clinical Journal,2022,10.2215/cjn.05270522,https://experts.mcmaster.ca/display/publication2424874,2025-07-27T15:14:40.642977
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,The Sound of Interconnectivity; The European Vasculitis Society 2022 Report,Kidney International Reports,2022,10.1016/j.ekir.2022.05.018,https://experts.mcmaster.ca/display/publication2336023,2025-07-27T15:14:40.642978
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Mechanical versus bioprosthetic valves in chronic dialysis: a systematic review and meta-analysis,Canadian Journal of Surgery,2022,10.1503/cjs.001121,https://experts.mcmaster.ca/display/publication2357462,2025-07-27T15:14:40.642979
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Impact of Bioelectrical Impedance–Guided Fluid Management and Vitamin D Supplementation on Left Ventricular Mass in Patients Receiving Peritoneal Dialysis: A Randomized Controlled Trial,American Journal of Kidney Diseases,2022,10.1053/j.ajkd.2021.08.022,https://experts.mcmaster.ca/display/publication2166044,2025-07-27T15:14:40.642980
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Association of anti-neutrophil cytoplasmic antibody-associated vasculitis and cardiovascular events: a population-based cohort study,CKJ: Clinical Kidney Journal,2022,10.1093/ckj/sfab229,https://experts.mcmaster.ca/display/publication2191877,2025-07-27T15:14:40.642981
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Plasma Exchange in ANCA-Associated Vasculitis: For Whom (If Any)?,Journal of the American Society of Nephrology,2022,10.1681/asn.2021121550,https://experts.mcmaster.ca/display/publication2173056,2025-07-27T15:14:40.642982
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Targeting the opioid pathway for the treatment of chronic kidney disease‐associated pruritus: a systematic review and meta‐analysis of randomized controlled trials,British Journal of Dermatology,2022,10.1111/bjd.20769,https://experts.mcmaster.ca/display/publication2145868,2025-07-27T15:14:40.642983
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Plasma exchange and glucocorticoid dosing for patients with ANCA-associated vasculitis: a clinical practice guideline,The BMJ,2022,10.1136/bmj-2021-064597,https://experts.mcmaster.ca/display/publication2172569,2025-07-27T15:14:40.642984
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,The effects of plasma exchange in patients with ANCA-associated vasculitis: an updated systematic review and meta-analysis,The BMJ,2022,10.1136/bmj-2021-064604,https://experts.mcmaster.ca/display/publication2172276,2025-07-27T15:14:40.642985
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,A systematic survey identified methodological issues in studies estimating anchor-based minimal important differences in patient-reported outcomes,Journal of Clinical Epidemiology,2022,10.1016/j.jclinepi.2021.10.028,https://experts.mcmaster.ca/display/publication2152510,2025-07-27T15:14:40.642986
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Comparative efficacy and safety of alternative glucocorticoids regimens in patients with ANCA-associated vasculitis: a systematic review,BMJ Open,2022,10.1136/bmjopen-2021-050507,https://experts.mcmaster.ca/display/publication2172277,2025-07-27T15:14:40.642987
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Mapping the Edmonton Symptom Assessment System-Revised: Renal to the EQ-5D-5L in patients with chronic kidney disease,Quality of Life Research,2022,10.1007/s11136-021-02948-5,https://experts.mcmaster.ca/display/publication2026330,2025-07-27T15:14:40.642988
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Phase 2 Study of the Factor XI Antisense Inhibitor IONIS-FXIRx in Patients With ESRD,Kidney International Reports,2022,10.1016/j.ekir.2021.11.011,https://experts.mcmaster.ca/display/publication2155696,2025-07-27T15:14:40.642989
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Improvement of kidney function in patients with chronic kidney disease and severe obesity after bariatric surgery: A systematic review and meta‐analysis,Nephrology,2022,10.1111/nep.13958,https://experts.mcmaster.ca/display/publication2105924,2025-07-27T15:14:40.642991
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Burden of mental health symptoms and perceptions of their management in in-centre hemodialysis care: a mixed methods study,Journal of Patient-Reported Outcomes,2021,10.1186/s41687-021-00385-z,https://experts.mcmaster.ca/display/publication2142158,2025-07-27T15:14:40.642992
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,High-Throughput Analysis of Changes in Protein Biomarkers During Hemodialysis,Journal of the American Society of Nephrology,2021,10.1681/asn.20213210s1317a,https://experts.mcmaster.ca/display/publication3431224,2025-07-27T15:14:40.642993
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Preferences Regarding Treatment with Plasma Exchange for ANCA-Associated Vasculitis: An International Patient Survey,Journal of the American Society of Nephrology,2021,10.1681/asn.20213210s1507c,https://experts.mcmaster.ca/display/publication3443612,2025-07-27T15:14:40.642994
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Use of Critical Items in Determining Point-of-Care Ultrasound Competence,Evaluation and the Health Professions,2021,10.1177/0163278720975833,https://experts.mcmaster.ca/display/publication1940708,2025-07-27T15:14:40.642999
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Predicting Myocardial Injury and Other Cardiac Complications After Elective Noncardiac Surgery with the Revised Cardiac Risk Index: The VISION Study,Canadian Journal of Cardiology,2021,10.1016/j.cjca.2021.03.015,https://experts.mcmaster.ca/display/publication1965081,2025-07-27T15:14:40.643000
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Prevalence of Frailty in Patients Referred to the Kidney Transplant Waitlist,Kidney360,2021,10.34067/kid.0001892021,https://experts.mcmaster.ca/display/publication2424560,2025-07-27T15:14:40.643001
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Three week compared to seven week run-in period length and the assessment of pre-randomization adherence: A study within a trial,Contemporary Clinical Trials,2021,10.1016/j.cct.2021.106466,https://experts.mcmaster.ca/display/publication1980491,2025-07-27T15:14:40.643002
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guideline,The BMJ,2021,10.1136/bmj.n1091,https://experts.mcmaster.ca/display/publication1968845,2025-07-27T15:14:40.643003
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Comparing Renal Replacement Therapy Modalities in Critically Ill Patients With Acute Kidney Injury: A Systematic Review and Network Meta-Analysis,Critical Care Explorations,2021,10.1097/cce.0000000000000399,https://experts.mcmaster.ca/display/publication1971522,2025-07-27T15:14:40.643004
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,POS-166 THE EFFECTS OF PLASMA EXCHANGE IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS,Kidney International Reports,2021,10.1016/j.ekir.2021.03.176,https://experts.mcmaster.ca/display/publication3443626,2025-07-27T15:14:40.643005
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,In Search of the Optimal Target for Phosphate Control: Episode 1,Journal of the American Society of Nephrology,2021,10.1681/asn.2021010027,https://experts.mcmaster.ca/display/publication1964302,2025-07-27T15:14:40.643006
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Nephrologist Views Regarding Cannabinoid Use in Advanced Chronic Kidney Disease and Dialysis: A Survey,Journal of Pain and Symptom Management,2021,10.1016/j.jpainsymman.2020.08.003,https://experts.mcmaster.ca/display/publication1922946,2025-07-27T15:14:40.643007
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials,The BMJ,2021,10.1136/bmj.m4573,https://experts.mcmaster.ca/display/publication1956945,2025-07-27T15:14:40.643008
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Variability in Cardiac Biomarkers during Hemodialysis: A Prospective Cohort Study,Clinical Chemistry,2021,10.1093/clinchem/hvaa299,https://experts.mcmaster.ca/display/publication1957150,2025-07-27T15:14:40.643009
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Examining therapeutic equivalence between branded and generic warfarin in Brazil: The WARFA crossover randomized controlled trial,PLoS ONE,2021,10.1371/journal.pone.0248567,https://experts.mcmaster.ca/display/publication1965097,2025-07-27T15:14:40.643010
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Incidence and Outcomes of Acute Kidney Injury in Patients Admitted to Hospital With COVID-19: A Retrospective Cohort Study,Canadian Journal of Kidney Health and Disease,2021,10.1177/20543581211027759,https://experts.mcmaster.ca/display/publication2026318,2025-07-27T15:14:40.643011
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,"MyTEMP: Statistical Analysis Plan of a Registry-Based, Cluster-Randomized Clinical Trial",Canadian Journal of Kidney Health and Disease,2021,10.1177/20543581211041182,https://experts.mcmaster.ca/display/publication2123871,2025-07-27T15:14:40.643012
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,The WISHED Randomized Controlled Trial: Impact of an Interactive Health Communication Application on Home Dialysis Use in People With Chronic Kidney Disease,Canadian Journal of Kidney Health and Disease,2021,10.1177/20543581211019631,https://experts.mcmaster.ca/display/publication1984768,2025-07-27T15:14:40.643013
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,A cluster randomized controlled trial for the Evaluation of routinely Measured PATient reported outcomes in HemodialYsis care (EMPATHY): a study protocol,BMC Health Services Research,2020,10.1186/s12913-020-05557-z,https://experts.mcmaster.ca/display/publication1922945,2025-07-27T15:14:40.643014
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Prerandomization run-in periods in randomized controlled trials of chronic diseases: a methodological study,Journal of Clinical Epidemiology,2020,10.1016/j.jclinepi.2020.09.035,https://experts.mcmaster.ca/display/publication1927537,2025-07-27T15:14:40.643015
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Fragility of clinical trials across research fields: A synthesis of methodological reviews,Contemporary Clinical Trials,2020,10.1016/j.cct.2020.106151,https://experts.mcmaster.ca/display/publication1925906,2025-07-27T15:14:40.643016
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses,CANADIAN MEDICAL ASSOCIATION JOURNAL,2020,10.1503/cmaj.200077,https://experts.mcmaster.ca/display/publication1922676,2025-07-27T15:14:40.643017
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Response to: ‘Mycophenolate mofetil: a step forward in the induction treatment of ANCA-associated vasculitis? Comment on the article by Joneset al’by Vandergheynstet al,Annals of the Rheumatic Diseases,2020,10.1136/annrheumdis-2019-215658,https://experts.mcmaster.ca/display/publication1646887,2025-07-27T15:14:40.643017
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Erratum to “A systematic survey identified 36 criteria for assessing effect modification claims in randomized trials or meta-analyses” [J Clin Epidemiol. 2019;113:159-67],Journal of Clinical Epidemiology,2020,10.1016/j.jclinepi.2020.04.003,https://experts.mcmaster.ca/display/publication1895894,2025-07-27T15:14:40.643018
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis,New England Journal of Medicine,2020,10.1056/nejmc2004843,https://experts.mcmaster.ca/display/publication1911544,2025-07-27T15:14:40.643019
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Association Between Myocardial Injury and Cardiovascular Outcomes of Orthopaedic Surgery,Journal of Bone and Joint Surgery. American volume,2020,10.2106/jbjs.18.01305,https://experts.mcmaster.ca/display/publication1695136,2025-07-27T15:14:40.643020
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,The association of beta-blocker use with mortality in elderly patients with congestive heart failure and advanced chronic kidney disease,Nephrology Dialysis Transplantation,2020,10.1093/ndt/gfz167,https://experts.mcmaster.ca/display/publication1665704,2025-07-27T15:14:40.643021
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis,New England Journal of Medicine,2020,10.1056/nejmoa1803537,https://experts.mcmaster.ca/display/publication1690012,2025-07-27T15:14:40.643022
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,PreoperativeN-Terminal Pro–B-Type Natriuretic Peptide and Cardiovascular Events After Noncardiac Surgery,ACP journal club,2020,10.7326/m19-2501,https://experts.mcmaster.ca/display/publication1684792,2025-07-27T15:14:40.643023
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Frailty and the Kidney Transplant Wait List: Protocol for a Multicenter Prospective Study,Canadian Journal of Kidney Health and Disease,2020,10.1177/2054358120957430,https://experts.mcmaster.ca/display/publication1926635,2025-07-27T15:14:40.643024
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,"Major Outcomes With Personalized Dialysate TEMPerature (MyTEMP): Rationale and Design of a Pragmatic, Registry-Based, Cluster Randomized Controlled Trial",Canadian Journal of Kidney Health and Disease,2020,10.1177/2054358119887988,https://experts.mcmaster.ca/display/publication1693799,2025-07-27T15:14:40.643025
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference,Kidney International,2020,10.1016/j.kint.2019.09.018,https://experts.mcmaster.ca/display/publication1676999,2025-07-27T15:14:40.643026
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,"The DIalysis Symptom COntrol-Restless Legs Syndrome (DISCO-RLS) Trial: A Protocol for a Randomized, Crossover, Placebo-Controlled Blinded Trial",Canadian Journal of Kidney Health and Disease,2020,10.1177/2054358120968959,https://experts.mcmaster.ca/display/publication1940305,2025-07-27T15:14:40.643027
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,A systematic survey identified 36 criteria for assessing effect modification claims in randomized trials or meta-analyses,Journal of Clinical Epidemiology,2019,10.1016/j.jclinepi.2019.05.014,https://experts.mcmaster.ca/display/publication1641975,2025-07-27T15:14:40.643028
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Screening questions for the diagnosis of restless legs syndrome in hemodialysis,CKJ: Clinical Kidney Journal,2019,10.1093/ckj/sfy129,https://experts.mcmaster.ca/display/publication1658258,2025-07-27T15:14:40.643029
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Association between complications and death within 30 days after noncardiac surgery,CANADIAN MEDICAL ASSOCIATION JOURNAL,2019,10.1503/cmaj.190221,https://experts.mcmaster.ca/display/publication1658791,2025-07-27T15:14:40.643030
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,FP687THE ASSOCIATION BETWEEN INTRA-DIALYTIC SYMPTOM CLUSTERS AND RECOVERY TIME IN PATIENTS UNDERGOING CHRONIC HEMODIALYSIS: AN EXPLORATORY ANALYSIS,Nephrology Dialysis Transplantation,2019,10.1093/ndt/gfz106.fp687,https://experts.mcmaster.ca/display/publication3398332,2025-07-27T15:14:40.643031
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference,Kidney International,2019,10.1016/j.kint.2019.02.022,https://experts.mcmaster.ca/display/publication1939608,2025-07-27T15:14:40.643032
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,SP677IMPLEMENTING A PATIENT-REPORTED OUTCOME MEASURE FOR HEMODIALYSIS PATIENTS IN ROUTINE CLINICAL CARE: PERSPECTIVES OF PATIENTS AND CLINICIANS,Nephrology Dialysis Transplantation,2019,10.1093/ndt/gfz103.sp677,https://experts.mcmaster.ca/display/publication1972322,2025-07-27T15:14:40.643033
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Change in albuminuria as a surrogate endpoint in chronic kidney disease,The Lancet Diabetes and Endocrinology,2019,10.1016/s2213-8587(19)30089-0,https://experts.mcmaster.ca/display/publication1638973,2025-07-27T15:14:40.643034
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Bioavailability of oral curcumin,CANADIAN MEDICAL ASSOCIATION JOURNAL,2019,10.1503/cmaj.71719,https://experts.mcmaster.ca/display/publication1939609,2025-07-27T15:14:40.643035
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Long-term low-dose maintenance glucocorticoids in ANCA vasculitis,Clinical Nephrology,2019,10.5414/cn109527,https://experts.mcmaster.ca/display/publication1636200,2025-07-27T15:14:40.643036
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Cardiovascular outcome trials in patients with chronic kidney disease: challenges associated with selection of patients and endpoints,European Heart Journal,2019,10.1093/eurheartj/ehx209,https://experts.mcmaster.ca/display/publication1124980,2025-07-27T15:14:40.643036
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Effect of methylprednisolone on acute kidney injury in patients undergoing cardiac surgery with a cardiopulmonary bypass pump: a randomized controlled trial,CANADIAN MEDICAL ASSOCIATION JOURNAL,2019,10.1503/cmaj.181644,https://experts.mcmaster.ca/display/publication1631420,2025-07-27T15:14:40.643037
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,160. VERITAS: VASCULITIS: EFFECTS OF REMISSION MAINTENANCE THERAPIES ON RELAPSE AND SIDE EFFECTS ON PATIENT PREFERENCES: A STUDY PROTOCOL,Rheumatology,2019,10.1093/rheumatology/kez059.037,https://experts.mcmaster.ca/display/publication2745894,2025-07-27T15:14:40.643038
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,A Mendelian Randomization-Based Approach to Identify Early and Sensitive Diagnostic Biomarkers of Disease,Clinical Chemistry,2019,10.1373/clinchem.2018.291104,https://experts.mcmaster.ca/display/publication1603994,2025-07-27T15:14:40.643040
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,"Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial",Annals of the Rheumatic Diseases,2019,10.1136/annrheumdis-2018-214245,https://experts.mcmaster.ca/display/publication1619002,2025-07-27T15:14:40.643041
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Canadian Nephrologist Views Regarding Stroke and Systemic Embolism Prevention in Dialysis Patients With Nonvalvular Atrial Fibrillation: A Survey,Canadian Journal of Kidney Health and Disease,2019,10.1177/2054358118821945,https://experts.mcmaster.ca/display/publication1623211,2025-07-27T15:14:40.643041
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Cultivating Innovative Pragmatic Cluster-Randomized Registry Trials Embedded in Hemodialysis Care: Workshop Proceedings From 2018,Canadian Journal of Kidney Health and Disease,2019,10.1177/2054358119894394,https://experts.mcmaster.ca/display/publication1686677,2025-07-27T15:14:40.643042
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Leveraging pragmatic clinical trial design to advance phosphate management in end-stage renal disease,Current Opinion in Nephrology and Hypertension,2019,10.1097/mnh.0000000000000460,https://experts.mcmaster.ca/display/publication1609684,2025-07-27T15:14:40.643043
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,"Renal relapse in antineutrophil cytoplasmic autoantibody-associated vasculitis: unpredictable, but predictive of renal outcome",Rheumatology,2019,10.1093/rheumatology/key260,https://experts.mcmaster.ca/display/publication1615474,2025-07-27T15:14:40.643044
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Single Questions for the Screening of Anxiety and Depression in Hemodialysis,Canadian Journal of Kidney Health and Disease,2019,10.1177/2054358118825441,https://experts.mcmaster.ca/display/publication1624670,2025-07-27T15:14:40.643045
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Prevalence and correlates of bleeding and emotional harms in a national US sample of patients with venous thromboembolism: A cross-sectional structural equation model,Thrombosis Research,2018,10.1016/j.thromres.2018.05.025,https://experts.mcmaster.ca/display/publication2145874,2025-07-27T15:14:40.643046
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Oral curcumin in elective abdominal aortic aneurysm repair: a multicentre randomized controlled trial,CANADIAN MEDICAL ASSOCIATION JOURNAL,2018,10.1503/cmaj.180510,https://experts.mcmaster.ca/display/publication1604071,2025-07-27T15:14:40.643047
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Blood HER2 and Uromodulin as Causal Mediators of CKD,Journal of the American Society of Nephrology,2018,10.1681/asn.2017070812,https://experts.mcmaster.ca/display/publication1504182,2025-07-27T15:14:40.643048
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,"HDL Cholesterol, LDL Cholesterol, and Triglycerides as Risk Factors for CKD: A Mendelian Randomization Study",American Journal of Kidney Diseases,2018,10.1053/j.ajkd.2017.06.011,https://experts.mcmaster.ca/display/publication1322500,2025-07-27T15:14:40.643049
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease (Can-SOLVE CKD): Form and Function,Canadian Journal of Kidney Health and Disease,2018,10.1177/2054358117749530,https://experts.mcmaster.ca/display/publication1495684,2025-07-27T15:14:40.643050
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Canadians seeking solutions and innovations to overcome chronic kidney disease (Can-SOLVE CKD): Form and function,Canadian Journal of Kidney Health and Disease,2018,10.1177/20543581177495,https://experts.mcmaster.ca/display/publication1724987,2025-07-27T15:14:40.643051
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial,PLoS ONE,2018,10.1371/journal.pone.0198285,https://experts.mcmaster.ca/display/publication1543685,2025-07-27T15:14:40.643052
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease-1: Study Protocol for a Multicenter Clinical Trial,Canadian Journal of Kidney Health and Disease,2018,10.1177/2054358118813088,https://experts.mcmaster.ca/display/publication1619001,2025-07-27T15:14:40.643053
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Barriers and facilitators to healthcare professional behaviour change in clinical trials using the Theoretical Domains Framework: a case study of a trial of individualized temperature-reduced haemodialysis,Trials,2017,10.1186/s13063-017-1965-9,https://experts.mcmaster.ca/display/publication1545539,2025-07-27T15:14:40.643054
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Discrimination and Calibration of Clinical Prediction Models,Journal of the American Medical Association (JAMA),2017,10.1001/jama.2017.12126,https://experts.mcmaster.ca/display/publication1467059,2025-07-27T15:14:40.643055
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease—Improving Global Outcomes (KDIGO) Controversies Conference,Kidney International,2017,10.1016/j.kint.2017.04.019,https://experts.mcmaster.ca/display/publication1124966,2025-07-27T15:14:40.643056
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,The Fragility of Statistically Significant Findings From Randomized Trials in Sports Surgery: A Systematic Survey,American Journal of Sports Medicine,2017,10.1177/0363546516674469,https://experts.mcmaster.ca/display/publication52809,2025-07-27T15:14:40.643057
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Two phosphAte taRGets in End-stage renal disease Trial (TARGET): A Randomized Controlled Trial,American Society of Nephrology. Clinical Journal,2017,10.2215/cjn.10941016,https://experts.mcmaster.ca/display/publication914840,2025-07-27T15:14:40.643057
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Association of Postoperative High-Sensitivity Troponin Levels With Myocardial Injury and 30-Day Mortality Among Patients Undergoing Noncardiac Surgery,Journal of the American Medical Association (JAMA),2017,10.1001/jama.2017.4360,https://experts.mcmaster.ca/display/publication52791,2025-07-27T15:14:40.643059
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,When is a meta-analysis conclusive? A guide to Trial Sequential Analysis with an example of remote ischemic preconditioning for renoprotection in patients undergoing cardiac surgery,Nephrology Dialysis Transplantation,2017,10.1093/ndt/gfw219,https://experts.mcmaster.ca/display/publication1124981,2025-07-27T15:14:40.643060
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,External validation of the Revised Cardiac Risk Index and update of its renal variable to predict 30-day risk of major cardiac complications after non-cardiac surgery: rationale and plan for analyses of the VISION study,BMJ Open,2017,10.1136/bmjopen-2016-013510,https://experts.mcmaster.ca/display/publication587617,2025-07-27T15:14:40.643061
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Plasmapheresis for the treatment of kidney diseases,Kidney International,2016,10.1016/j.kint.2016.06.009,https://experts.mcmaster.ca/display/publication1527497,2025-07-27T15:14:40.643062
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,ANCA-Associated Glomerulonephritis: Risk Factors for Renal Relapse,PLoS ONE,2016,10.1371/journal.pone.0165402,https://experts.mcmaster.ca/display/publication1124991,2025-07-27T15:14:40.643063
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,The WISHED Trial: Implementation of an Interactive Health Communication Application for Patients with Chronic Kidney Disease,Canadian Journal of Kidney Health and Disease,2016,10.1186/s40697-016-0120-y,https://experts.mcmaster.ca/display/publication1125015,2025-07-27T15:14:40.643064
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial,Annals of the Rheumatic Diseases,2015,10.1136/annrheumdis-2014-206404,https://experts.mcmaster.ca/display/publication1125073,2025-07-27T15:14:40.643065
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Comparability of patients with ANCA-associated vasculitis enrolled in clinical trials or in observational cohorts,Clinical and Experimental Rheumatology,2015,,https://experts.mcmaster.ca/display/publication638690,2025-07-27T15:14:40.643066
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,"Endothelin-1, but not angiotensin II, induces afferent arteriolar myosin diphosphorylation as a potential contributor to prolonged vasoconstriction",Kidney International,2015,10.1038/ki.2014.284,https://experts.mcmaster.ca/display/publication1527556,2025-07-27T15:14:40.643067
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,CanVasc Recommendations for the Management of Antineutrophil Cytoplasm Antibody (ANCA)-Associated Vasculitides – Executive Summary,Canadian Journal of Kidney Health and Disease,2015,10.1186/s40697-015-0078-1,https://experts.mcmaster.ca/display/publication1021573,2025-07-27T15:14:40.643068
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Establishing a Canadian National Clinical Trials Network for Kidney Disease: Proceedings of a Planning Workshop,Canadian Journal of Kidney Health and Disease,2015,10.1186/s40697-015-0080-7,https://experts.mcmaster.ca/display/publication1125046,2025-07-27T15:14:40.643069
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Perioperative Aspirin and Clonidine and Risk of Acute Kidney Injury,Journal of the American Medical Association (JAMA),2014,10.1001/jama.2014.15284,https://experts.mcmaster.ca/display/publication551053,2025-07-27T15:14:40.643070
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use prior to major elective surgery and the risk of acute dialysis,BMC Nephrology,2014,10.1186/1471-2369-15-53,https://experts.mcmaster.ca/display/publication725200,2025-07-27T15:14:40.643071
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Randomized trial of enteric-coated mycophenolate sodium versus mycophenolate mofetil in multi-system autoimmune disease,CKJ: Clinical Kidney Journal,2014,10.1093/ckj/sfu096,https://experts.mcmaster.ca/display/publication1125070,2025-07-27T15:14:40.643072
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,The impact of patient preference on dialysis modality and hemodialysis vascular access,BMC Nephrology,2014,10.1186/1471-2369-15-38,https://experts.mcmaster.ca/display/publication1125125,2025-07-27T15:14:40.643073
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Kidney Function After Off-Pump or On-Pump Coronary Artery Bypass Graft Surgery,Journal of the American Medical Association (JAMA),2014,10.1001/jama.2014.4952,https://experts.mcmaster.ca/display/publication457403,2025-07-27T15:14:40.643074
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Canadian Society of Nephrology Commentary on the 2012 KDIGO Clinical Practice Guideline for Glomerulonephritis: Management of Glomerulonephritis in Adults,American Journal of Kidney Diseases,2014,10.1053/j.ajkd.2013.12.001,https://experts.mcmaster.ca/display/publication1125131,2025-07-27T15:14:40.643075
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Canadian Society of Nephrology Commentary on the 2012 KDIGO Clinical Practice Guideline for Glomerulonephritis: Management of Nephrotic Syndrome in Children,American Journal of Kidney Diseases,2014,10.1053/j.ajkd.2013.12.002,https://experts.mcmaster.ca/display/publication1125130,2025-07-27T15:14:40.643076
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Economic Evaluation of Frequent Home Nocturnal Hemodialysis Based on a Randomized Controlled Trial,Journal of the American Society of Nephrology,2014,10.1681/asn.2013040360,https://experts.mcmaster.ca/display/publication1125143,2025-07-27T15:14:40.643077
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Myocardial Injury after Noncardiac Surgery,Anesthesiology,2014,10.1097/aln.0000000000000113,https://experts.mcmaster.ca/display/publication53045,2025-07-27T15:14:40.643078
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Steroids In caRdiac Surgery (SIRS) trial: acute kidney injury substudy protocol of an international randomised controlled trial,BMJ Open,2014,10.1136/bmjopen-2014-004842,https://experts.mcmaster.ca/display/publication457415,2025-07-27T15:14:40.643079
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Aspirin and clonidine in non-cardiac surgery: acute kidney injury substudy protocol of the Perioperative Ischaemic Evaluation (POISE) 2 randomised controlled trial,BMJ Open,2014,10.1136/bmjopen-2014-004886,https://experts.mcmaster.ca/display/publication551025,2025-07-27T15:14:40.643080
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Establishing a National Knowledge Translation and Generation Network in Kidney Disease: The CAnadian KidNey KNowledge TraNslation and GEneration NeTwork,Canadian Journal of Kidney Health and Disease,2014,10.1186/2054-3581-1-2,https://experts.mcmaster.ca/display/publication547123,2025-07-27T15:14:40.643081
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,The Steroids in the Maintenance of Remission of Proliferative Lupus Nephritis (SIMPL) Pilot Trial,Canadian Journal of Kidney Health and Disease,2014,10.1186/s40697-014-0030-9,https://experts.mcmaster.ca/display/publication1125136,2025-07-27T15:14:40.643082
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,The Risk of Perioperative Bleeding in Patients With Chronic Kidney Disease,Annals of Surgery,2013,10.1097/sla.0000000000000244,https://experts.mcmaster.ca/display/publication587753,2025-07-27T15:14:40.643082
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Estimated GFR Reporting Influences Recommendations for Dialysis Initiation,Journal of the American Society of Nephrology,2013,10.1681/asn.2013010035,https://experts.mcmaster.ca/display/publication591791,2025-07-27T15:14:40.643083
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,The Association Between Perioperative Hemoglobin and Acute Kidney Injury in Patients Having Noncardiac Surgery,Anesthesia and Analgesia,2013,10.1213/ane.0b013e3182a1ec84,https://experts.mcmaster.ca/display/publication587731,2025-07-27T15:14:40.643084
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Progressive multifocal leukoencephalopathy with gastrointestinal disease in a pediatric kidney transplant recipient,Pediatric Transplantation,2013,10.1111/petr.12107,https://experts.mcmaster.ca/display/publication1125151,2025-07-27T15:14:40.643085
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,"European Vasculitis Study (EUVAS) investigators: Intravenous cyclophosphamide and plasmapheresis in dialysis-dependent ANCA-associated vasculitis (vol 8, pg 219, 2013)",American Society of Nephrology. Clinical Journal,2013,,https://experts.mcmaster.ca/display/publication1581264,2025-07-27T15:14:40.643086
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Intravenous Cyclophosphamide and Plasmapheresis in Dialysis-Dependent ANCA-Associated Vasculitis,American Society of Nephrology. Clinical Journal,2013,10.2215/cjn.03680412,https://experts.mcmaster.ca/display/publication1125178,2025-07-27T15:14:40.643087
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,"Association of Calcium, Phosphate and Parathyroid Hormone with Renal Allograft Function: A Retrospective Cohort Study",American Journal of Nephrology,2013,10.1159/000348376,https://experts.mcmaster.ca/display/publication1125165,2025-07-27T15:14:40.643088
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Increased cardiovascular risk after pre‐eclampsia in women with dysglycaemia,Diabetic Medicine,2013,10.1111/dme.12033,https://experts.mcmaster.ca/display/publication201363,2025-07-27T15:14:40.643089
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Reply,Arthritis and Rheumatism,2012,10.1002/art.34588,https://experts.mcmaster.ca/display/publication1581261,2025-07-27T15:14:40.643090
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Timing the initiation of renal replacement therapy for acute kidney injury in Canadian intensive care units: a multicentre observational study,Canadian Journal of Anaesthesia,2012,10.1007/s12630-012-9750-4,https://experts.mcmaster.ca/display/publication270754,2025-07-27T15:14:40.643091
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Secular trends in acute dialysis after elective major surgery — 1995 to 2009,CANADIAN MEDICAL ASSOCIATION JOURNAL,2012,10.1503/cmaj.110895,https://experts.mcmaster.ca/display/publication942422,2025-07-27T15:14:40.643093
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Timing of initiation of renal replacement therapy for acute kidney injury: a survey of nephrologists and intensivists in Canada,Nephrology Dialysis Transplantation,2012,10.1093/ndt/gfr740,https://experts.mcmaster.ca/display/publication1125221,2025-07-27T15:14:40.643094
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,"Error in Viewpoint in: Statin Therapy for Healthy Men Identified as ‘Increased Risk,’",Journal of the American Medical Association (JAMA),2012,10.1001/jama.2012.6832,https://experts.mcmaster.ca/display/publication1740984,2025-07-27T15:14:40.643095
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Association Between Postoperative Troponin Levels and 30-Day Mortality Among Patients Undergoing Noncardiac Surgery,Journal of the American Medical Association (JAMA),2012,10.1001/jama.2012.5502,https://experts.mcmaster.ca/display/publication53156,2025-07-27T15:14:40.643096
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Clinical factors associated with initiation of renal replacement therapy in critically ill patients with acute kidney injury—A prospective multicenter observational study,Journal of Critical Care,2012,10.1016/j.jcrc.2011.06.003,https://experts.mcmaster.ca/display/publication270788,2025-07-27T15:14:40.643097
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Tubular Lesions Predict Renal Outcome in Antineutrophil Cytoplasmic Antibody–Associated Glomerulonephritis after Rituximab Therapy,Journal of the American Society of Nephrology,2012,10.1681/asn.2011040330,https://experts.mcmaster.ca/display/publication1125226,2025-07-27T15:14:40.643098
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Coronary Artery Bypass Grafting Surgery Off- or On-pump Revascularisation Study (CORONARY): kidney substudy analytic protocol of an international randomised controlled trial,BMJ Open,2012,10.1136/bmjopen-2012-001080,https://experts.mcmaster.ca/display/publication457462,2025-07-27T15:14:40.643099
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Peritoneal Dialysis Patients with Critical Illness: Insurance May be Hard to Come By,Advances in peritoneal dialysis. Conference on Peritoneal Dialysis,2012,10.3747/pdi.2011.00111,https://experts.mcmaster.ca/display/publication1125213,2025-07-27T15:14:40.643100
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Statin Use Associates with a Lower Incidence of Acute Kidney Injury after Major Elective Surgery,Journal of the American Society of Nephrology,2011,10.1681/asn.2010050442,https://experts.mcmaster.ca/display/publication687193,2025-07-27T15:14:40.643101
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,The Effect of Nocturnal and Conventional Hemodialysis on Markers of Nutritional Status: Results From a Randomized Trial,Journal of Renal Nutrition,2011,10.1053/j.jrn.2010.04.004,https://experts.mcmaster.ca/display/publication1125288,2025-07-27T15:14:40.643102
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Preventing Relapses in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis—Reply,Journal of the American Medical Association (JAMA),2011,10.1001/jama.2011.239,https://experts.mcmaster.ca/display/publication1581262,2025-07-27T15:14:40.643103
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,An international prospective cohort study evaluating major vascular complications among patients undergoing noncardiac surgery: the VISION Pilot Study.,Open Medicine,2011,,https://experts.mcmaster.ca/display/publication910576,2025-07-27T15:14:40.643104
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,The Number of Patients and Events Required to Limit the Risk of Overestimation of Intervention Effects in Meta-Analysis—A Simulation Study,PLoS ONE,2011,10.1371/journal.pone.0025491,https://experts.mcmaster.ca/display/publication624094,2025-07-27T15:14:40.643105
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Association between routine and standardized blood pressure measurements and left ventricular hypertrophy among patients on hemodialysis,BMC Nephrology,2010,10.1186/1471-2369-11-13,https://experts.mcmaster.ca/display/publication1125297,2025-07-27T15:14:40.643106
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Early and late initiation of dialysis did not differ for reduction of all-cause mortality in stage 5 chronic kidney disease,ACP journal club,2010,10.7326/0003-4819-153-10-201011160-02002,https://experts.mcmaster.ca/display/publication1125272,2025-07-27T15:14:40.643107
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Early and late initiation of dialysis did not differ for reduction of all-cause mortality in stage 5 chronic kidney disease,Annals of Internal Medicine,2010,10.1059/0003-4819-153-10-201011160-02002,https://experts.mcmaster.ca/display/publication1541880,2025-07-27T15:14:40.643108
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis,New England Journal of Medicine,2010,10.1056/nejmoa0909169,https://experts.mcmaster.ca/display/publication1125289,2025-07-27T15:14:40.643108
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Kidney Disease After Preeclampsia: A Systematic Review and Meta-analysis,American Journal of Kidney Diseases,2010,10.1053/j.ajkd.2009.12.036,https://experts.mcmaster.ca/display/publication206119,2025-07-27T15:14:40.643109
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Generalized pruritic eruption in a patient with chronic kidney disease,Dermatology Online Journal,2010,10.5070/d37s48c7kf,https://experts.mcmaster.ca/display/publication1096537,2025-07-27T15:14:40.643110
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,The effects of nocturnal compared with conventional hemodialysis on mineral metabolism: A randomized‐controlled trial,Hemodialysis International,2010,10.1111/j.1542-4758.2009.00418.x,https://experts.mcmaster.ca/display/publication1125328,2025-07-27T15:14:40.643111
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Ascorbic Acid for Anemia Management in Hemodialysis Patients: A Systematic Review and Meta-analysis,American Journal of Kidney Diseases,2009,10.1053/j.ajkd.2009.06.040,https://experts.mcmaster.ca/display/publication1125339,2025-07-27T15:14:40.643112
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Nocturnal hemodialysis does not improve overall measures of quality of life compared to conventional hemodialysis,Kidney International,2009,10.1038/ki.2008.639,https://experts.mcmaster.ca/display/publication1527498,2025-07-27T15:14:40.643113
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Monoclonal gammopathy and glomerulopathy associated with chronic lymphocytic leukemia,Nature Reviews Nephrology,2009,10.1038/ncpneph0989,https://experts.mcmaster.ca/display/publication1125367,2025-07-27T15:14:40.643114
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Association between Multidisciplinary Care and Survival for Elderly Patients with Chronic Kidney Disease,Journal of the American Society of Nephrology,2007,10.1681/asn.2006080860,https://experts.mcmaster.ca/display/publication1125461,2025-07-27T15:14:40.643115
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,The effects of nocturnal hemodialysis compared to conventional hemodialysis on change in left ventricular mass: Rationale and study design of a randomized controlled pilot study,BMC Nephrology,2006,10.1186/1471-2369-7-2,https://experts.mcmaster.ca/display/publication1125489,2025-07-27T15:14:40.643116
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Novel predictors of overt nephropathy in subjects with type 1 diabetes. A nested case control study from the Pittsburgh Epidemiology of Diabetes Complications cohort,Nephrology Dialysis Transplantation,2006,10.1093/ndt/gfi103,https://experts.mcmaster.ca/display/publication1125513,2025-07-27T15:14:40.643117
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,Reply from the Authors,Kidney International,2005,10.1111/j.1523-1755.2005.00583_12.x,https://experts.mcmaster.ca/display/publication1527527,2025-07-27T15:14:40.643118
Michael Walsh,mwwalsh@mcmaster.ca,journal_articles,"A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life",Kidney International,2005,10.1111/j.1523-1755.2005.00228.x,https://experts.mcmaster.ca/display/publication1125538,2025-07-27T15:14:40.643119
Michael Walsh,mwwalsh@mcmaster.ca,chapters,General Management of the Hemodialysis Patient,,2022,10.1002/9781119105954.ch42,https://experts.mcmaster.ca/display/publication3414711,2025-07-27T15:14:40.643120
Michael Walsh,mwwalsh@mcmaster.ca,chapters,Stroke and Atrial Fibrillation in Chronic Kidney Disease and Dialysis,,2019,10.1016/b978-0-323-55429-9.00014-5,https://experts.mcmaster.ca/display/publication2525909,2025-07-27T15:14:40.643121
Michael Walsh,mwwalsh@mcmaster.ca,conferences,Chronic kidney disease-mineral and bone disorder: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.,Kidney International,2025,10.1016/j.kint.2024.11.013,https://experts.mcmaster.ca/display/publication3545139,2025-07-27T15:14:40.643122
Michael Walsh,mwwalsh@mcmaster.ca,conferences,The Association Between Intradialytic Symptom Clusters and Recovery Time in Patients Undergoing Maintenance Hemodialysis: An Exploratory Analysis,Canadian Journal of Kidney Health and Disease,2024,10.1177/20543581241237322,https://experts.mcmaster.ca/display/publication1679479,2025-07-27T15:14:40.643123
Michael Walsh,mwwalsh@mcmaster.ca,conferences,Characteristics of Relapse of Individuals With ANCA-Associated Vasculitis Enrolled in the PEXIVAS Trial,Journal of Rheumatology,2023,,https://experts.mcmaster.ca/display/publication3304648,2025-07-27T15:14:40.643124
Michael Walsh,mwwalsh@mcmaster.ca,conferences,The Effects of Initial Treatment on Relapse of ANCA-Associated Vasculitis in the PEXIVAS Trial,Journal of Rheumatology,2023,,https://experts.mcmaster.ca/display/publication3304649,2025-07-27T15:14:40.643125
Michael Walsh,mwwalsh@mcmaster.ca,conferences,"Clinical Trial Considerations in Developing Treatments for Early Stages of Common, Chronic Kidney Diseases: A Scientific Workshop Cosponsored by the National Kidney Foundation and the US Food and Drug Administration",American Journal of Kidney Diseases,2022,10.1053/j.ajkd.2022.03.011,https://experts.mcmaster.ca/display/publication2428079,2025-07-27T15:14:40.643126
Michael Walsh,mwwalsh@mcmaster.ca,conferences,Characteristics and Outcomes of Participants with and Without Diffuse Alveolar Hemorrhage in the Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis (PEXIVAS) Trial,Arthritis & Rheumatology,2022,,https://experts.mcmaster.ca/display/publication2686905,2025-07-27T15:14:40.643127
Michael Walsh,mwwalsh@mcmaster.ca,conferences,Implementing a Patient-Reported Outcome Measure for Hemodialysis Patients in Routine Clinical Care,American Society of Nephrology. Clinical Journal,2020,10.2215/cjn.01840220,https://experts.mcmaster.ca/display/publication1679473,2025-07-27T15:14:40.643127
Michael Walsh,mwwalsh@mcmaster.ca,conferences,The Fragility of Statistically Significant Randomized Controlled Trials in Plastic Surgery,Plastic and Reconstructive Surgery,2019,10.1097/prs.0000000000006102,https://experts.mcmaster.ca/display/publication1676806,2025-07-27T15:14:40.643128
Michael Walsh,mwwalsh@mcmaster.ca,conferences,A new instrument to assess the credibility of effect modification analyses (ICEMAN) in randomized controlled trials and meta-analyses,Trials,2019,,https://experts.mcmaster.ca/display/publication1673151,2025-07-27T15:14:40.643129
Michael Walsh,mwwalsh@mcmaster.ca,conferences,ASSESSING SYMPTOM ASSESSMENT AND MANAGEMENT PROCESSES FOLLOWING THE ADMINISTRATION OF A PATIENT-REPORTED OUTCOME MEASURE TO HEMODIALYSIS PATIENTS IN ONTARIO,Nephrology Dialysis Transplantation,2019,,https://experts.mcmaster.ca/display/publication2145869,2025-07-27T15:14:40.643130
Michael Walsh,mwwalsh@mcmaster.ca,conferences,THE SAFETY AND EFFICACY OF GLUCOCORTICOIDS IN IGA NEPHROPATHY: A SYSTEMATIC REVIEW AND META-ANALYSIS,Nephrology Dialysis Transplantation,2019,,https://experts.mcmaster.ca/display/publication1680394,2025-07-27T15:14:40.643131
Michael Walsh,mwwalsh@mcmaster.ca,conferences,THE EFFECT OF PLASMA EXCHANGE ON END-STAGE RENAL DISEASE AND DEATH IN PATIENTS WITH SEVERE ANCA-ASSOCIATED VASCULITIS,Rheumatology,2019,,https://experts.mcmaster.ca/display/publication2145870,2025-07-27T15:14:40.643133
Michael Walsh,mwwalsh@mcmaster.ca,conferences,THE EFFECT OF REDUCED-DOSE ORAL GLUCOCORTICOIDS DURING INDUCTION OF REMISSION INDUCTION IN SEVERE ANCA-ASSOCIATED VASCULITIS,Rheumatology,2019,,https://experts.mcmaster.ca/display/publication2145871,2025-07-27T15:14:40.643134
Michael Walsh,mwwalsh@mcmaster.ca,conferences,UTILIZATION OF CANADIAN HEALTHCARE ADMINISTRATIVE DATABASES TO ACCURATELY IDENTIFY CASES OF ANCA-ASSOCIATED VASCULITIS,Rheumatology,2019,,https://experts.mcmaster.ca/display/publication1660030,2025-07-27T15:14:40.643135
Michael Walsh,mwwalsh@mcmaster.ca,conferences,VERITAS: VASCULITIS: EFFECTS OF REMISSION MAINTENANCE THERAPIES ON RELAPSE AND SIDE EFFECTS ON PATIENT PREFERENCES: A STUDY PROTOCOL,Rheumatology,2019,,https://experts.mcmaster.ca/display/publication1660058,2025-07-27T15:14:40.643136
Michael Walsh,mwwalsh@mcmaster.ca,conferences,The Effects of Plasma Exchange and Reduced-Dose Glucocorticoids during Remission-Induction for Treatment of Severe ANCA-Associated Vasculitis,Arthritis & Rheumatology,2018,,https://experts.mcmaster.ca/display/publication2145872,2025-07-27T15:14:40.643137
Michael Walsh,mwwalsh@mcmaster.ca,conferences,"Pharmacokinetics and Pharmacodynamics of Ionis-FXIRx, an Antisense Inhibitor of Factor XI, in Patients with End-Stage Renal Disease on Hemodialysis",Blood,2017,,https://experts.mcmaster.ca/display/publication2145873,2025-07-27T15:14:40.643138
Michael Walsh,mwwalsh@mcmaster.ca,conferences,THE STEROID TAPERING IN ANCA VASCULITIS EVALUATION STUDY (STAVE) 2: A SYSTEMATIC REVIEW AND META-ANALYSIS,Nephrology Dialysis Transplantation,2017,,https://experts.mcmaster.ca/display/publication1646419,2025-07-27T15:14:40.643138
Michael Walsh,mwwalsh@mcmaster.ca,conferences,DEMOGRAPHIC CHARACTERISTICS OF JAPANESE PARTICIPANTS IN PEXIVAS AS COMPARED WITH REMIT-JAV,Rheumatology,2017,,https://experts.mcmaster.ca/display/publication2145875,2025-07-27T15:14:40.643139
Michael Walsh,mwwalsh@mcmaster.ca,conferences,PLASMA EXCHANGE AND GLUCOCORTICOID DOSING IN THE TREATMENT OF ANTI-NEUTROPHIL CYTOPLASM ANTIBODY ASSOCIATED VASCULITIS: BASELINE CHARACTERISTICS OF A RANDOMIZED CONTROLLED TRIAL (PEXIVAS),Rheumatology,2017,,https://experts.mcmaster.ca/display/publication1527484,2025-07-27T15:14:40.643140
Michael Walsh,mwwalsh@mcmaster.ca,conferences,"TWO INTERNATIONAL MULTIREGIONAL INVESTIGATOR INITIATED CLINICAL TRIALS ON VASCULITIS: COLLABORATION WITH EUVAS, VCRC AND NATIONWIDE VASCULITIS STUDY GROUPS OF JAPAN",Rheumatology,2017,,https://experts.mcmaster.ca/display/publication1527493,2025-07-27T15:14:40.643141
Michael Walsh,mwwalsh@mcmaster.ca,conferences,Establishing Core Outcome Domains in Hemodialysis: Report of the Standardized Outcomes in Nephrology–Hemodialysis (SONG-HD) Consensus Workshop,American Journal of Kidney Diseases,2017,10.1053/j.ajkd.2016.05.022,https://experts.mcmaster.ca/display/publication1746414,2025-07-27T15:14:40.643142
Michael Walsh,mwwalsh@mcmaster.ca,conferences,EFFECTS OF ISCHAEMIC CONDITIONING ON MAJOR CLINICAL OUTCOMES: A SYSTEMATIC REVIEWAND META-ANALYSIS,Nephrology,2016,,https://experts.mcmaster.ca/display/publication985917,2025-07-27T15:14:40.643143
Michael Walsh,mwwalsh@mcmaster.ca,conferences,THE EFFECTIVENESS OF PHARMACOLOGICAL AND NON-PHARMACOLOGICAL INTERVENTIONS IN IMPROVING RESTLESS LEGS SYNDROME SEVERITY AMONG PATIENTS ON DIALYSIS: A SYSTEMATIC REVIEW,Journal of Epidemiology and Community Health,2015,10.1136/jech-2014-205217.2,https://experts.mcmaster.ca/display/publication1522055,2025-07-27T15:14:40.643144
Michael Walsh,mwwalsh@mcmaster.ca,conferences,A randomized trial of mycophenolate mofetil versus cyclophosphamide for remission induction of ANCA-associated vasculitis: “MYCYC”. On behalf of the European vasculitis study group,Presse Medicale,2013,10.1016/j.lpm.2013.02.067,https://experts.mcmaster.ca/display/publication1527494,2025-07-27T15:14:40.643145
Michael Walsh,mwwalsh@mcmaster.ca,conferences,Predicting renal relapse with the histopathologic classification of ANCA-associated glomerulonephritis,Presse Medicale,2013,10.1016/j.lpm.2013.02.233,https://experts.mcmaster.ca/display/publication1581263,2025-07-27T15:14:40.643146
Michael Walsh,mwwalsh@mcmaster.ca,conferences,Can Low-Molecular-Weight Heparin Be Safely Used as Prophylaxis Against Venous Thromboembolism in Critically Ill Patients with End-Stage Renal Disease? A Subgroup Analysis of the Protect Trial,American Journal of Hematology,2012,,https://experts.mcmaster.ca/display/publication218258,2025-07-27T15:14:40.643147
Michael Walsh,mwwalsh@mcmaster.ca,conferences,Optimal Definition for the Duration of Sustained Remission in ANCA-Associated Vasculitis,Arthritis and Rheumatism,2011,,https://experts.mcmaster.ca/display/publication2132520,2025-07-27T15:14:40.643148
Michael Walsh,mwwalsh@mcmaster.ca,conferences,The prevalence of preoperative elevations in troponin T above the 99th percentile using the troponin T high sensitive assay in patients undergoing noncardiac surgery,Clinical Biochemistry,2011,10.1016/j.clinbiochem.2011.06.037,https://experts.mcmaster.ca/display/publication587717,2025-07-27T15:14:40.643149
Michael Walsh,mwwalsh@mcmaster.ca,conferences,Alveolar haemorrhage in ANCA-AAV: an analysis of EUVAS trials,Clinical and Experimental Immunology,2011,,https://experts.mcmaster.ca/display/publication1527480,2025-07-27T15:14:40.643150
Michael Walsh,mwwalsh@mcmaster.ca,conferences,Measurement of health-related quality of life among patients with ANCA-AAV using the SF-36,Clinical and Experimental Immunology,2011,,https://experts.mcmaster.ca/display/publication1520850,2025-07-27T15:14:40.643151
Michael Walsh,mwwalsh@mcmaster.ca,conferences,PEXIVAS: design of an RCT of PLEX and GC dosing in the treatment of severe ANCA-AAV,Clinical and Experimental Immunology,2011,,https://experts.mcmaster.ca/display/publication1581265,2025-07-27T15:14:40.643152
Michael Walsh,mwwalsh@mcmaster.ca,conferences,"Pulse versus daily oral CyP for induction of remission in ANCA-associated vasculitis. A European, multi-centre randomized controlled trial: long-term follow-up",Clinical and Experimental Immunology,2011,,https://experts.mcmaster.ca/display/publication1527504,2025-07-27T15:14:40.643153
Michael Walsh,mwwalsh@mcmaster.ca,conferences,Two-year follow-up results from a randomized trial of RTX versus CyP for ANCA-associated renal vasculitis: RITUXVAS,Clinical and Experimental Immunology,2011,,https://experts.mcmaster.ca/display/publication1527563,2025-07-27T15:14:40.643154
Michael Walsh,mwwalsh@mcmaster.ca,conferences,RITUXIMAB VERSUS CYCLOPHOSPHAMIDE IN ANCA ASSOCIATED RENAL VASCULITIS,Nephrology,2010,,https://experts.mcmaster.ca/display/publication1527611,2025-07-27T15:14:40.643155
Michael Walsh,mwwalsh@mcmaster.ca,conferences,Health-related quality of life in ANCA-associated vasculitis treated with a rituximab-based regimen vs cyclophosphamide,"APMIS : acta pathologica, microbiologica, et immunologica Scandinavica",2009,,https://experts.mcmaster.ca/display/publication1581266,2025-07-27T15:14:40.643155
Michael Walsh,mwwalsh@mcmaster.ca,conferences,Health-related quality of life in patients with ANCA-associated vasculitis: a pooled analysis of four randomized clinical trials,"APMIS : acta pathologica, microbiologica, et immunologica Scandinavica",2009,,https://experts.mcmaster.ca/display/publication1527479,2025-07-27T15:14:40.643156
Michael Walsh,mwwalsh@mcmaster.ca,conferences,Optimizing the Birmingham vasculitis activity scale to predict end-stage renal disease and death in ANCA-associated vasculitis,"APMIS : acta pathologica, microbiologica, et immunologica Scandinavica",2009,,https://experts.mcmaster.ca/display/publication1581267,2025-07-27T15:14:40.643157
Michael Walsh,mwwalsh@mcmaster.ca,conferences,Plasma exchange in ANCA-associated vasculitis: a systematic review and meta-analysis,"APMIS : acta pathologica, microbiologica, et immunologica Scandinavica",2009,,https://experts.mcmaster.ca/display/publication1581259,2025-07-27T15:14:40.643158
Michael Walsh,mwwalsh@mcmaster.ca,conferences,Predictors of long-term (>= 5 year) renal survival in 535 patients with ANCA-associated vasculitis,"APMIS : acta pathologica, microbiologica, et immunologica Scandinavica",2009,,https://experts.mcmaster.ca/display/publication1581258,2025-07-27T15:14:40.643159
Michael Walsh,mwwalsh@mcmaster.ca,conferences,Randomized trial of mycophenolate mofetil vs azathioprine for maintenance therapy in ANCA-associated vasculitis (IMPROVE),"APMIS : acta pathologica, microbiologica, et immunologica Scandinavica",2009,,https://experts.mcmaster.ca/display/publication1527487,2025-07-27T15:14:40.643160
Michael Walsh,mwwalsh@mcmaster.ca,conferences,Randomized trial of rituximab vs cyclophosphamide for ANCA-associated renal vasculitis: RITUXVAS,"APMIS : acta pathologica, microbiologica, et immunologica Scandinavica",2009,,https://experts.mcmaster.ca/display/publication1527642,2025-07-27T15:14:40.643161
Michael Walsh,mwwalsh@mcmaster.ca,conferences,The association between relapses of ANCA-associated vasculitis and the composite endpoint of end-stage renal disease or death,"APMIS : acta pathologica, microbiologica, et immunologica Scandinavica",2009,,https://experts.mcmaster.ca/display/publication1581260,2025-07-27T15:14:40.643162
Michael Walsh,mwwalsh@mcmaster.ca,conferences,A systematic review and meta-analysis of relapses in AAV: What is the effect of low-dose corticosteroids?,Nephrology Dialysis Transplantation,2007,,https://experts.mcmaster.ca/display/publication1527582,2025-07-27T15:14:40.643163
Michael Walsh,mwwalsh@mcmaster.ca,conferences,Long-term follow-up of relapsing/refractory ANCA associated vasculitis treated with the lymphocyte depleting antibody Alemtuzumab (CAMPATH-1H),Nephrology Dialysis Transplantation,2007,,https://experts.mcmaster.ca/display/publication1527516,2025-07-27T15:14:40.643164
